ALK immunohistochemistry is highly sensitive and specific for the detection of ALK translocated lung adenocarcinomas: lessons from an audit of lung cancer molecular testing
Background The approval of novel targeted treatments for epidermal growth factor receptor (EGFR)-positive and anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer has led to the increased requirement for mutation testing. Results We report our experience of ALK testing with immun...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Royal College of Physicians of Edinburgh
2018-03-01
|
Series: | The Journal of the Royal College of Physicians of Edinburgh |
Subjects: | |
Online Access: | https://www.rcpe.ac.uk/sites/default/files/jrcpe_48_1_oniscu.pdf |